Attached files

file filename
10-K - FORM 10-K - TRIMEDYNE INCtmed_10k-093012.htm
EX-32.1 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3201.htm
EX-32.2 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3202.htm
EX-31.2 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3102.htm
EX-31.1 - CERTIFICATION - TRIMEDYNE INCtmed_10k-ex3101.htm
EXCEL - IDEA: XBRL DOCUMENT - TRIMEDYNE INCFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR2.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR8.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR1.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR5.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR3.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR4.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR7.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR9.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR6.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR41.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR18.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR53.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR54.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR47.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR19.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR16.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR17.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR52.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR33.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR37.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR34.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR51.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR49.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR12.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR21.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR38.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR15.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR22.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR14.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR45.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR25.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR42.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR39.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR32.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR48.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR10.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR36.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR40.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR55.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR46.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR35.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR28.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR20.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR24.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR23.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR30.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR27.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR11.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR13.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR31.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR26.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR29.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR43.htm
XML - IDEA: XBRL DOCUMENT - TRIMEDYNE INCR50.htm
v2.4.0.6
10. Segment Reporting by Operating activities (Details) (USD $)
12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Revenue $ 6,080,000 $ 6,656,000
Cost of sales 4,083,000 4,574,000
Gross profit 1,997,000 2,082,000
Expenses:    
Selling, general and administrative 2,494,000 2,751,000
Research and development 673,000 853,000
Income (loss) from operations (1,170,000) (1,522,000)
Other:    
Interest income    3,000
Interest expense (10,000) (62,000)
Royalty income 116,000 96,000
Net gain on sale of patents 200,000 0
Creditor settlements and recoveries 41,000 1,000
Change in fair market value of derivative liabilities 0 43,000
Loss on extinguishment of note payable 0 (36,000)
Loss before provision for income taxes (823,000) (1,477,000)
Provision for income taxes 13,000 9,000
Net loss (836,000) (1,486,000)
Products
   
Revenue 3,588,000 3,930,000
Cost of sales 2,467,000 2,871,000
Gross profit 1,121,000 1,059,000
Expenses:    
Selling, general and administrative 1,872,000 2,051,000
Research and development 673,000 853,000
Income (loss) from operations (1,424,000) (1,845,000)
Service and rental
   
Revenue 2,492,000 2,726,000
Cost of sales 1,616,000 1,703,000
Gross profit 876,000 1,023,000
Expenses:    
Selling, general and administrative 622,000 700,000
Research and development      
Income (loss) from operations $ 254,000 $ 323,000